Advanced Solid Tumors That Are MTAP Deficient
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| azd3470 | ASTRAZENECA PLC (AZN) |
Frequently asked questions
How many drugs are in development for Advanced Solid Tumors That Are MTAP Deficient?
BioSniper tracks 1 drug in development for Advanced Solid Tumors That Are MTAP Deficient across 1 company.
How many clinical trials target Advanced Solid Tumors That Are MTAP Deficient?
There are 1 clinical trial targeting Advanced Solid Tumors That Are MTAP Deficient tracked by BioSniper.
Deep-dive into Advanced Solid Tumors That Are MTAP Deficient
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis